Douglas Love
Directeur Général chez ANNEXON, INC.
Fortune : 838 992 $ au 30/04/2024
Profil
Douglas Love's current job(s) include being the President, Chief Executive Officer & Director at Annexon, Inc. since 2014 and also holding the same titles at Annexon Biosciences, Inc.Mr. Love's former job(s) include working as a Corporate Counsel at Amgen, Inc. from 1999 to 2001, as a Corporate Counsel at Genentech, Inc. from 2001 to 2006, as the Head-Operations & Strategic Alliances at Elan Pharmaceuticals LLC from 2008 to 2013, and as an Associate at Orrick, Herrington & Sutcliffe LLP from 1996 to 1999.
Mr. Love completed his undergraduate degree at the University of Southern California in 1991 and obtained his graduate degree from Mcgeorge School of Law in 1995.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ANNEXON, INC.
0,17% | 01/03/2024 | 182 787 ( 0,17% ) | 838 992 $ | 30/04/2024 |
Postes actifs de Douglas Love
| Sociétés | Poste | Début |
|---|---|---|
| ANNEXON, INC. | Directeur Général | 01/12/2014 |
| Annexon Biosciences, Inc. | Directeur Général | - |
Anciens postes connus de Douglas Love
| Sociétés | Poste | Fin |
|---|---|---|
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/04/2013 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Conseiller Juridique Général | 01/01/2006 |
| AMGEN INC. | Conseiller Juridique Général | 01/01/2001 |
Orrick, Herrington & Sutcliffe LLP
 Orrick, Herrington & Sutcliffe LLP Miscellaneous Commercial ServicesCommercial Services Orrick, Herrington & Sutcliffe LLP engages in the provision of legal services. Its practices include: antitrust and competition; banking and finance; capital markets; copyright, trademark and false advertising; cyber, privacy and data innovation; employment law and litigation; energy; financial services litigation; global compliance and regulatory, infrastructure; intellectual property; patents; public finance; real estate; securities litigation; supreme court and appellate; tax advocacy; technology transactions; trials; and white collar, investigations, securities litigation and compliance. The company was founded by John R. Garboe in 1863 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | 01/01/1999 |
Formation de Douglas Love
| Mcgeorge School of Law | Graduate Degree |
| University of Southern California | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ANNEXON, INC. | Health Technology |
| AMGEN INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Elan Pharmaceuticals, LLC
Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Health Technology |
Orrick, Herrington & Sutcliffe LLP
Orrick, Herrington & Sutcliffe LLP Miscellaneous Commercial ServicesCommercial Services Orrick, Herrington & Sutcliffe LLP engages in the provision of legal services. Its practices include: antitrust and competition; banking and finance; capital markets; copyright, trademark and false advertising; cyber, privacy and data innovation; employment law and litigation; energy; financial services litigation; global compliance and regulatory, infrastructure; intellectual property; patents; public finance; real estate; securities litigation; supreme court and appellate; tax advocacy; technology transactions; trials; and white collar, investigations, securities litigation and compliance. The company was founded by John R. Garboe in 1863 and is headquartered in San Francisco, CA. | Commercial Services |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
| Annexon Biosciences, Inc. |